Prestige Consumer Healthcare, Inc. (PBH) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Apellis Pharmaceuticals, Inc.

Insmed, Inc.

ACADIA Pharmaceuticals, Inc.

Amicus Therapeutics, Inc.

Prestige Consumer Healthcare, Inc.

Organon & Co.

Perrigo Co. Plc

Alkermes Plc

Cerevel Therapeutics Holdings, Inc.

MoonLake Immunotherapeutics

Bausch Health Cos., Inc.

Why is Prestige Consumer Healthcare, Inc. ?

Poor long term growth as Net Sales has grown by an annual rate of 3.13% and Operating profit at 3.08% over the last 5 years

Flat results in Jun 25

NET SALES(Q) Lowest at USD 249.53 MM
OPERATING PROFIT(Q) Lowest at USD 79.42 MM
NET PROFIT(Q) Lowest at USD 47.47 MM

With ROCE of 12.76%, it has a fair valuation with a 1.99 Enterprise value to Capital Employed

The stock is trading at a fair value compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -27.16%, its profits have risen by 6.6% ; the PEG ratio of the company is 3

Below par performance in long term as well as near term

Along with generating -27.16% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Prestige Consumer Healthcare, Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Prestige Consumer Healthcare, Inc. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Prestige Consumer Healthcare, Inc.

-39.11%

-0.26

28.69%

S&P 500

19.75%

0.70

20.15%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

2.90%

EBIT Growth (5y)

2.19%

EBIT to Interest (avg)

5.29

Debt to EBITDA (avg)

3.40

Net Debt to Equity (avg)

0.49

Sales to Capital Employed (avg)

0.40

Tax Ratio

24.49%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

11.87%

ROE (avg)

14.20%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.67

EV to EBIT

12.03

EV to EBITDA

11.04

EV to Capital Employed

1.43

EV to Sales

3.65

PEG Ratio

Dividend Yield

ROCE (Latest)

11.92%

ROE (Latest)

10.66%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD 257.63 MM

EPS(Q)

Highest at USD 1.13

-8What is not working for the Company

ROCE(HY)

Lowest at 10.22%

INTEREST COVERAGE RATIO(Q)

Lowest at 733.67

RAW MATERIAL COST(Y)

Grown by 10.27% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.64 times

INTEREST(Q)

Highest at USD 11.43 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 29.77 %

Here's what is working for Prestige Consumer Healthcare, Inc.

Operating Cash Flow

Highest at USD 257.63 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

EPS

Highest at USD 1.13

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Depreciation

Highest at USD 8.35 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Prestige Consumer Healthcare, Inc.

Interest Coverage Ratio

Lowest at 733.67

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest

Highest at USD 11.43 MM

in the last five periods and Increased by 7.08% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Profit Margin

Lowest at 29.77 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Debtors Turnover Ratio

Lowest at 5.64 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 10.27% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales